Id2 specifically alters regulation of the cell cycle by tumor suppressor proteins

Molecular and Cellular Biology

Volumn 16, Issue 6, 1996, Pages 2570-2578

  Lasorella, A ^a   Iavarone, A ^a,b   Israel, M A ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HELIX LOOP HELIX PROTEIN;

ARTICLE; CELL CYCLE; CELL DIFFERENTIATION; CELL PROLIFERATION; GROWTH REGULATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR SUPPRESSOR GENE;

EID: 0029929792     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.16.6.2570     Document Type: Article

References (74)

1. Barone, M. V., R. Pepperkok, F. A. Peverali, and L. Philipson. 1994. Id proteins control growth induction in mammalian cells. Proc. Natl. Acad. Sci. USA 91:4985-4988.
2. 1 cyclin complexes. Genes Dev. 9:1340-1353.
3. Benezra, R., R. L. Davis, D. Lockshon, D. L. Turner, and H. Weintraub. 1990. The protein Id: a negative regulator of helix-loop-helix DNA binding proteins. Cell 61:49-59.
4. Biggs, J., E. V. Murphy, and M. A. Israel. 1992. A human Id-like helix-loop-helix protein expressed during early development. Proc. Natl. Acad. Sci. USA 89:1512-1516.
5. Buchkovich, K., L. A. Duffy, and E. Harlow. 1989. The retinoblastoma protein is phosphorylated during specific phases of the cell cycle. Cell 58:1097-1105.
6. Cao, L., B. Faha, M. Dembski, L.-H. Tsai, E. Harlow, and N. Dyson. 1992. Independent binding of the retinoblastoma protein and p 107 to the transcription factor E2F. Nature (London) 355:176-179.
7. Cardoso, M. C., H. Leonhardt, and B. Nadal-Ginard. 1993. Reversal of terminal differentiation and control of DNA replication: cyclin A and Cdk2 specifically localize at subnuclear sites of DNA replication. Cell 74:979-992.
8. INK4. Mol. Cell. Biol. 15:2682-2688.
9. Chellappan, S. P., S. Hiebert, M. Mudryj, M. J. Horowitz, and J. R. Nevins. 1991. The E2F transcription factor is a cellular target for the RB protein. Cell 65:1053-1061.
10. Chen, P. L., P. Scully, J. Y. Shew, J. Y. Wang, and W. H. Lee. 1989 Phosphorylation of the retinoblastoma gene product is modulated during the cell cycle and cellular differentiation. Cell 58:1193-1198.
11. Christy, B. A., L. K. Sanders, L. F. Lau, N. G. Copeland, N. A. Jenkins, and D. Nathans. 1991. An Id-related helix-loop-helix protein encoded by a growth factor-inducible gene. Proc. Natl. Acad. Sci. USA 88:1815-1819.
12. Cobrinik, D., P. Whyle, D. S. Peeper, T. Jacks, and R. A. Weinberg. 1993. Cell cycle-specific association of E2F with the p130 E1A-binding protein. Genes Dev. 7:2392-2404.
13. Cordle, S. R., E. Henderson, H. Masucha, P. A. Weil, and R. Stein. 1991. Pancreatic β-cell-type-specific transcription of the insulin gene is mediated by basic helix-loop-helix DNA-binding proteins. Mol. Cell. Biol. 11:1734-1738.
14. DeCaprio, J. A., J. W. Ludlow, J. Figge, J. Y. Shew, C. M. Huang, W. H. Lee, E. Marsilio, E. Paucha, and M. Livingston. 1988. SV40 large tumor antigen forms a specific complex with the product of the retinoblastoma susceptibility gene. Cell 54:275-283.
15. DeCaprio, J. A., J. W. Ludlow, D. Lynch, Y. Furukawa, J. Griffin, H. Piwnica-Worms, C. M. Huang, and D. M. Livingston. 1989. The product of the retinoblastoma susceptibility gene has properties of a cell cycle regulatory element. Cell 58:1085-1095.
16. Dowdy, S. F., P. W. Hinds, K. Louie, S. I. Reed, A. Arnold, and R. A. Weinberg. 1993. Physical interaction of the retinoblastoma protein with human D cyclins. Cell 73:499-511
17. Eckner, R., M. E. Ewen, D. Newsome, M. Gerdes, J. A. DeCaprio, J. B. Lawrence, and D. M. Livingstone. 1994. Molecular cloning and functional analysis of the adenovirus E1A-associated 300-kD protein (p300) reveals a protein with properties of a transcriptional adaptor. Genes Dev. 8:869-884.
18. El-Deiry, W. S., T. Tokino, V. E. Velculescu, D. B. Levy, R. Parsons, J. M. Trent, D. Lin, E. Mercer, K. W. Kinzler, and B. Vogelstein. 1993. WAF1, a potential mediator of p53 tumor suppression. Cell 75:817-825.
19. Ellmeier, W., A. Aguzzi, E. Kleiner, R. Kurzbauer, and A. Weith. 1992. Mutually exclusive expression of a helix-loop-helix gene and N-myc in human neuroblastomas and in normal development. EMBO J. 11:2563-2571.
20. Ewen, M. E., H. K. Sluss, C. J. Sherr, H. Matsushime, J. Kato, and D. M. Livingston. 1993. Functional interactions of the retinoblastoma protein with mammalian D-type cyclins. Cell 73:487-497.
21. Ewen, M. E., Y. Xing, J. B. Lawrence, and D. M. Livingstone. 1991. Molecular cloning, chromosomal mapping and expression of the cDNA for p107, a retinoblastoma gene product-related protein. Cell 66:1155-1164.
22. Faha, B., M. E. Ewen, L. H. Tsai, D. M. Livingston, and E. Harlow. 1992. Interaction between human cyclin A and adenovirus E1A-associatcd p107 protein. Science 255:87-90.
23. Goodrich, D. W., N. P. Wamg, Y. W. Qian, E. Y. Lee, and W. H. Lee. 1991. The retinoblastoma gene product regulates progression through the G1 phase of the cell cycle. Cell 67:293-302.
24. Gu, W., J. W. Schneider, G. Condorelli, S. Kaushal, V. Mahdavi, and B. Nadal-Ginard. 1993. Interaction of myogenic factors and the retinoblastoma protein mediates muscle cell commitment and differentiation. Cell 72:309-324.
25. Gu, Y., C. W. Turek, and D. O. Morgan. 1993. Inhibition of CDK2 activity in vivo by an associated 20K regulatory suhunit. Nature (London) 366:707-710.
26. INK4/MST2-related CDK6 inhibitor, correlates with wild type pRb function. Genes Dev. 8:2939-2952.
27. INK4H is a potential effector of TGF-b-induced cell cycle arrest. Nature (London) 371:257-261.
28. Hannon, G., D. Demetrick, and D. Beach. 1993. Isolation of the Rb-related p130 through its interaction with CDK2 and cyclins. Genes Dev. 7:2378-2391.
29. 1 progression and are repressed in senescent human fibroblasts. J. Biol. Chem. 269:2139-2145.
30. Harper, J. W., G. R. Adami, N. Wei, K. Keyomarsi, and S. J. Elledge. 1993. The p21 cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinascs. Cell 75:805-816.
31. Helin, K., J. A. Lees, M. Vidal, N. Dyson, E. Harlow, and A. Fattaey. 1992. A cDNA encoding a pRB-binding protein with properties of the transcription factor E2F. Cell 70:337-350.
32. 31a.Hernandez, M. C. Personal communication.
33. Hinds, P. W., S. Mittnacht, V. Dulic, A. Arnold, S. I. Reed, and R. A. Weinberg. 1992. Regulation of retinoblastoma protein function by ectopic expression of human cyclins. Cell 70:993-1006.
34. Hirai, H., M. F. Roussel, J. Kato, R. A. Ashmun, and C. J. Sherr. 1995. Novel INK4 proteins, p19 and p18, are specific inhibitors of cyclin D-dependent kinase CDK4 and CDK6. Mol. Cell. Biol. 15:2672-2681.
35. Iavarone, A., P. Garg, A. Lasorella, J. Hsu, and M. A. Israel. 1994. The helix-loop-helix protein Id2 enhances cell proliferation and binds to the retinoblastoma protein. Genes Dev. 8:1270-1284.
36. Jen, Y., H. Weintraub, and R. Benezra. 1992. Overexpression of Id protein inhibits the muscle differentiation program: in vivo association of Id with E2A proteins. Genes Dev. 6:1466-1479.
37. Koh, J., G. H. Enders, B. D. Dynlacht, and E. Harlow. 1995. Tumor-derived p16 alleles encoding proteins defective in cell-cycle inhibition. Nature (London) 375:506-510.
38. Kratzke, R. A., G. A. Otterson, A. Y. Lin, E. Shimizu, N. Alexandrova, M. Zajac-Kaye, J. M. Horowitz, and F. J. Kaye. 1992. Functional analysis at the Cys706 residue of the retinoblastoma protein. J. Biol. Chem. 267:25998-26003.
39. Kreider, B. L., R. Benezra, G. Rovera, and T. Kadesch. 1992. Inhibition of myeloid differentiation by the helix-loop-helix protein Id. Science 255:1700-1702.
40. KIP2, a cyclin-dependent kinase inhibitor with unique domain structure and distribution. Genes Dev. 9:639-649.
41. Lees, E., B. Faha, V. Dulic, S. I. Reed, and E. Harlow. 1992. Cyclin E/cdk2 and cyclin A/cdk2 kinases associate with p107 and E2F in a temporally distinct manner. Genes Dev. 6:1874-1885.
42. Li, Y., C. Graham, S. Lacy, A. Duncan, and P. Whyte. 1993. The adenovirus E1A-associatcd 130-kD protein is encoded by a member of the retinoblastoma gene family and physically interacts with cyclins A and E. Genes Dev. 7:2366-2377.
43. 1 control in retinoblastoma gene-deficient cells independently of cdk4 activity. Mol. Cell. Biol. 15:2600-2611.
44. Lukas, J., H. Muller, J. Bartkova, D. Spitkovsky, A. A. Kjerulff, P. Jansen-Durr, M. Strauss, and J. Bartek. 1994. DNA tumor virus oncoproteins and retinoblastoma gene mutations share the ability to relieve the cell's requirement for cyclin D1 function in G1. J. Cell Biol. 125:625-638.
45. Lukas, J., D. Parry, L. Aagaard, D. J. Mann, J. Bartokova, M. Strauss, G. Peters, and J. Bartek. 1995. Retinoblastoma protein-dependent cell-cycle inhibition by the tumor suppressor p16. Nature (London) 375:503-506.
46. KIP2, a structurally distinct member of the p21CIP1 cdk inhibitor family, is a candidate tumor suppressor gene. Genes Dev. 9:650-662.
47. PSKJ3/CDK4) for mammalian D-type cyclins. Cell 71:323-334.
48. Medema, R. H., R. E. Herrera, F. Lam, and R. A. Weinberg. 1995. Growth suppression by p16ink4 requires functional retinoblastoma protein. Proc. Natl. Acad. Sci. USA 92:6289-6293.
49. Munger, K., B. A. Werness, N. Dyson, W. C. Phelps, E. Harlow, and P. M. Howley. 1989. Complex formation of human papillomavirus E7 protein with the retinoblastoma tumor suppressor gene product. EMBO J. 8:4099-4105.
50. Nagata, Y., W. Shoji, M. Obinata, and K. Todokoro. 1995. Phosphorylation of helix-loop-helix proteins Id1, Id2 and Id3. Biochem. Biophys. Res. Commun. 207:916-926.
51. INK4/MTS1 tumor suppressor gene product. EMBO J. 14:503-511.
52. 1 progression by E2A and Id helix-loop-helix proteins. EMBO J. 13:4291-4301.
53. Philipp, A., A. Schneider, I. Vasrik, K. Finke, Y. Xiong, D. Beach, K. Alitalo, and M. Eilers. 1994. Repression of cyclin D1: a novel function of MYC. Mol. Cell. Biol. 14:4032-4043.
54. Kip1, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals. Cell 78:59-66.
55. Qin, X. Q., T. Chittenden, D. M. Livingstone, and W. G. Kaelin. 1992. Identification of a growth suppression domain within the retinoblastoma gene product. Genes Dev. 6:953-964.
56. Riechmann, V., I. van Cruchten, and F. Sablitzky. 1994. The expression pattern of Id4, a novel dominant negative helix-loop-helix protein, is distinct from Id1, Id2 and Id3. Nucleic Acids Res. 22:749-755.
57. Rutzgi, A. K., N. Dyson, and R. Bernards. 1991. Amino-terminal domains of c-myc and n-myc proteins mediate binding to the retinoblastoma gene product. Nature (London) 352:541-544.
58. Schneider, J. W., W. Gu, L. Zhu, V. Mahdavi, and B. Nadal-Ginard. 1994. Reversal of terminal differentiation mediated by p107 in Rb-/- muscle cells. Science 264:1467-1471.
59. INK4 Science 267:249-252.
60. Serrano, M., G. J. Hannon, and D. Beach. 1993. A new regulatory motif in cell cycle control causing specific inhibition of cyclinD/Cdk4. Nature (London) 366:704-706.
61. 1 cyclin-dependent kinases. Genes Dev. 9:1149-1163.
62. Shirodkar, S. M., M. Ewen, J. A. De Caprio, D. Morgan, D. M. Livingston, and T. Chittenden. 1992. The transcription factor E2F interacts with the retinoblastoma product and a p107-cyclin A complex in a cell cycle-regulated manner. Cell 68:157-166.
63. Sun, X. H., N. G. Copeland, N. A. Jenkins, and D. Baltimore. 1991, Id proteins Id1 and Id2 selectively inhibit DNA binding by one class of helix-loop-helix proteins. Mol. Cell. Biol. 11:5003-5611.
64. Szekely, L., W. Q. Jiang, F. Bulic-Jakus, A. Rosen, N. Ringertz, G. Klein, and K. G. Wiman. 1992. Cell type and differentiation dependent heterogeneity in retinoblastoma protein expression in SCID mouse fetuses. Cell Growth Differ. 3:149-156.
65. Templeton, D. J., S. H. Park, L. Lanier, and R. A. Weinberg. 1991. Nonfunctional mutants of the retinoblastoma protein are characterized by defects in phosphorylation, viral oncoprotein association, and nuclear tethering. Proc. Natl. Acad. Sci. USA 88:3033-3037.
66. Toyoshima, H., and T. Hunter. 1994. p27, a novel inhibitor of G1 cyclin-cdk protein kinase activity, is related to p21. Cell 78:67-74.
67. Vairo, G., D. M. Livingstone, and D. Ginsberg. 1995. Functional interaction between E2F-4 and p 130: evidence for distinct mechanisms underlying growth suppression by different retinoblastoma protein family members. Genes Dev. 9:869-881.
68. Voronova, A. F., and F. Lee. 1994. The E2A and Tal-1 helix-loop-helix proteins associate in vivo and are modulated by Id proteins during interleukin 6-induced myeloid differentiation. Proc. Natl. Acad. Sci. USA 91:5952-5956.
69. Weinberg, R. A. 1995. The retinoblastoma protein and cell cycle control. Cell 81:323-330.
70. Whyte, P., K. J. Buchkovich, J. M. Horowitz, S. H. Friend, M. Raybuck, R. A. Weinberg, and E. Harlow. 1988. Association between an oncogene and an anti-oncogene: the adenovirus E1A proteins bind to the retinoblastoma gene product. Nature (London) 334:124-129.
71. Wilson, R. B., M. Kiledjian, C. P. Shen, R. Benezra, P. Zwollo, S. M. Dymecki, S. V. Desiderio, and T. Kadesch. 1991. Repression of immunoglobulin enhancers by the helix-loop-helix protein Id: implications for B-lymphoid-cell development. Mol. Cell. Biol. 11:6185-6191.
72. Xiong, Y., G. J. Hannen, H. Zhang, D. Casso, R. Kobayashi, and D. Beach. 1993. p21 is a universal inhibitor of cyclin kinases. Nature (London) 366:701-704.
73. Zhu, L., S. van den Heuvel, K. Helin, A. Fattaey, M. Ewen, D. M. Living-stone, N. Dyson, and E. Harlow. 1993. Inhibition of cell proliferation by p107, a relative of the retinoblastoma protein. Genes Dev. 7:1111-1125.
74. Zhu, W. J., J. Dahmen, A. Bulfone, M. Rigolet, M. C. Hernandez, W. Kuo, L. Puelles, J. L. Rubinstein, and M. A. Israel. 1995. Id gene expression during development and molecular cloning of the human Id-1 gene. Mol. Brain Res. 30:312-326.